![Tord Labuda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tord Labuda
Vorstandsvorsitzender bei
ALZINOVA AB
Profil
Tord Labuda is Chief Executive Officer at Alzinova AB since 2024 and Independent Director at NanoEcho AB since 2023.
Formerly, Dr. Labuda was Vice President & Global Head-Clinical Development at LEO Pharma A from 2008 to 2023.
Education includes a doctorate from the University of Lund.
Aktive Positionen von Tord Labuda
| Unternehmen | Position | Beginn |
|---|---|---|
| NANOECHO AB | Direktor/Vorstandsmitglied | 01.01.2023 |
| ALZINOVA AB | Vorstandsvorsitzender | 01.10.2024 |
Ehemalige bekannte Positionen von Tord Labuda
| Unternehmen | Position | Ende |
|---|---|---|
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Corporate Officer/Principal | 01.01.2023 |
Ausbildung von Tord Labuda
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
21
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Nanoecho AB
 Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
